Bradford Seagraves's questions to Nutex Health (NUTX) leadership • Q2 2025
Question
Bradford Seagraves requested commentary on business performance and free cash flow trends quarter-to-date in Q3 and asked if the company planned to publish unaudited Q2 financial statements ahead of the full restated filing.
Answer
CFO John Bates indicated that the strong and consistent operational trends seen in the first half of 2025 have continued into Q3 but did not provide specific figures. He explained that while the company will consider providing more data, the immediate focus is on the restatement process, which primarily impacts non-cash items and does not change the business's strong fundamentals.